Abivax SA (ABVX)
117.10
+0.30
(+0.26%)
USD |
NASDAQ |
Jan 16, 16:00
121.21
+4.11
(+3.51%)
Pre-Market: 08:58
Abivax Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 962.04B |
| DBV Technologies SA | 514.74M |
| Inventiva SA | 898.16M |
| Cellectis SA | 335.32M |
| Innate Pharma SA | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -179.21M |
| Total Expenses (Quarterly) | 179.21M |
| EPS Diluted (Quarterly) | -2.457 |